Compare Wockhardt with Sun Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WOCKHARDT vs SUN PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WOCKHARDT SUN PHARMA WOCKHARDT/
SUN PHARMA
 
P/E (TTM) x -100.6 30.4 - View Chart
P/BV x 1.3 4.1 32.1% View Chart
Dividend Yield % 0.0 0.9 -  

Financials

 WOCKHARDT   SUN PHARMA
EQUITY SHARE DATA
    WOCKHARDT
Mar-21
SUN PHARMA
Mar-21
WOCKHARDT/
SUN PHARMA
5-Yr Chart
Click to enlarge
High Rs570654 87.2%   
Low Rs174339 51.3%   
Sales per share (Unadj.) Rs249.3139.6 178.6%  
Earnings per share (Unadj.) Rs62.29.5 652.8%  
Cash flow per share (Unadj.) Rs84.418.2 463.8%  
Dividends per share (Unadj.) Rs07.50 0.0%  
Avg Dividend yield %01.5 0.0%  
Book value per share (Unadj.) Rs302.3193.6 156.1%  
Shares outstanding (eoy) m110.782,399.34 4.6%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x1.53.6 42.0%   
Avg P/E ratio x6.052.1 11.5%  
P/CF ratio (eoy) x4.427.3 16.2%  
Price / Book Value ratio x1.22.6 48.0%  
Dividend payout %078.8 0.0%   
Avg Mkt Cap Rs m41,1881,190,430 3.5%   
No. of employees `000NANA-   
Total wages/salary Rs m7,63068,622 11.1%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m27,620334,981 8.2%  
Other income Rs m1,5348,592 17.9%   
Total revenues Rs m29,155343,573 8.5%   
Gross profit Rs m12,57541,616 30.2%  
Depreciation Rs m2,46020,800 11.8%   
Interest Rs m2,4911,414 176.1%   
Profit before tax Rs m9,15927,994 32.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,2735,147 44.2%   
Profit after tax Rs m6,88622,847 30.1%  
Gross profit margin %45.512.4 366.5%  
Effective tax rate %24.818.4 135.0%   
Net profit margin %24.96.8 365.5%  
BALANCE SHEET DATA
Current assets Rs m24,244304,421 8.0%   
Current liabilities Rs m31,182161,456 19.3%   
Net working cap to sales %-25.142.7 -58.9%  
Current ratio x0.81.9 41.2%  
Inventory Days Days30149 20.3%  
Debtors Days Days1299 12.3%  
Net fixed assets Rs m49,508336,682 14.7%   
Share capital Rs m5542,399 23.1%   
"Free" reserves Rs m32,939462,229 7.1%   
Net worth Rs m33,492464,628 7.2%   
Long term debt Rs m5,0298,981 56.0%   
Total assets Rs m73,752641,103 11.5%  
Interest coverage x4.720.8 22.5%   
Debt to equity ratio x0.20 776.7%  
Sales to assets ratio x0.40.5 71.7%   
Return on assets %12.73.8 336.0%  
Return on equity %20.64.9 418.1%  
Return on capital %30.26.2 487.0%  
Exports to sales %00-   
Imports to sales %1.80-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m498NA-   
Fx inflow Rs m1,00984,493 1.2%   
Fx outflow Rs m49830,334 1.6%   
Net fx Rs m51154,159 0.9%   
CASH FLOW
From Operations Rs m-2,87361,704 -4.7%  
From Investments Rs m14,7015,362 274.2%  
From Financial Activity Rs m-11,708-59,805 19.6%  
Net Cashflow Rs m1295,964 2.2%  

Share Holding

Indian Promoters % 67.1 54.5 123.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.0 34.0 8.9%  
FIIs % 2.9 13.0 22.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 32.9 45.5 72.2%  
Shareholders   165,270 680,800 24.3%  
Pledged promoter(s) holding % 47.3 4.8 987.9%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WOCKHARDT With:   LUPIN    CIPLA    AUROBINDO PHARMA    DR. REDDYS LAB    CADILA HEALTHCARE    



Today's Market

SGX Nifty Tanks 294 Points, Maruti Suzuki Quarterly Results, Oyo's Rs 84 bn IPO, and Buzzing Stocks Today(Pre-Open)

Indian share markets ended on a positive note on Tuesday. Benchmark indices snapped their five-day losing run and ended on a positive note in a highly volatile session.

Related Views on News

SUN PHARMA 2020-21 Annual Report Analysis (Annual Result Update)

Oct 22, 2021 | Updated on Oct 22, 2021

Here's an analysis of the annual report of SUN PHARMA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

WOCKHARDT 2020-21 Annual Report Analysis (Annual Result Update)

Sep 6, 2021 | Updated on Sep 6, 2021

Here's an analysis of the annual report of WOCKHARDT for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of WOCKHARDT. Also includes updates on the valuation of WOCKHARDT.

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

Sun Pharma Zooms 10% as June Quarter Earnings Beat Estimates (Views On News)

Jul 30, 2021

Here's a rundown on Sun Pharma's June quarter results.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

More Views on News

Most Popular

These 5 Penny Stocks are Held by Rakesh Jhunjhunwala. Worth a Look?(Views On News)

Jan 18, 2022

Rakesh Jhunjhunwala is holding these penny stocks in his portfolio for several years now.

Time to Buy Energy Stocks(Fast Profits Daily)

Jan 14, 2022

Energy is a sector that looks set to take off. It's time to get in.

Tech Mahindra's CTC Acquisition: Too Expensive?(Views On News)

Jan 18, 2022

Tech Mahindra's acquisition of European IT-company fails to excite investors.

5 Hidden Tata Group Companies to Add to Your Watchlist(Views On News)

Jan 18, 2022

Here's all you need to know about these five Tata group stocks that aren't as popular as the others.

Insiders are Buying into these 6 Stocks Aggressively. More Details here...(Views On News)

Jan 19, 2022

While promoter holding is an important parameter, it should not be the sole reason for buying a stock.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

WOCKHARDT SHARE PRICE


Jan 27, 2022 09:24 AM

TRACK WOCKHARDT

  • Track your investment in WOCKHARDT with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

WOCKHARDT 8-QTR ANALYSIS

COMPARE WOCKHARDT WITH

MARKET STATS